Lista de obras - Herman Staats - Dominio Público Uruguay

A Mast Cell Degranulation Screening Assay for the Identification of Novel Mast Cell Activating Agents

artículo científico publicado en 2013

A comparative evaluation of nasal and parenteral vaccine adjuvants to elicit systemic and mucosal HIV-1 peptide-specific humoral immune responses in cynomolgus macaques

artículo científico publicado en 2004

A comparison of non-toxin vaccine adjuvants for their ability to enhance the immunogenicity of nasally-administered anthrax recombinant protective antigen.

artículo científico publicado en 2013

A mastoparan-derived peptide has broad-spectrum antiviral activity against enveloped viruses

artículo científico publicado en 2013

Alphavirus replicon particles acting as adjuvants promote CD8+ T cell responses to co-delivered antigen.

artículo científico publicado en 2008

An entirely cell-based system to generate single-chain antibodies against cell surface receptors

artículo científico publicado en 2008

Bridging Vaccine-Induced HIV-1 Neutralizing and Effector Antibody Responses in Rabbit and Rhesus Macaque Animal Models

scientific article published on 01 May 2019

Capric acid and hydroxypropylmethylcellulose increase the immunogenicity of nasally administered peptide vaccines

scientific article published on 01 June 2006

Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies.

artículo científico publicado en 2005

Chaperoning vaccines

artículo científico publicado en 2010

Cytokines as adjuvants for the induction of anti-human immunodeficiency virus peptide immunoglobulin G (IgG) and IgA antibodies in serum and mucosal secretions after nasal immunization

artículo científico publicado en 2002

Cytokines: the future of intranasal vaccine adjuvants.

artículo científico

Detection of Mucosal Antibodies in HIV Type 1-Infected Individuals

article

Development of a bead immunoassay to measure Vi polysaccharide-specific serum IgG after vaccination with the Salmonella enterica serovar Typhi Vi polysaccharide

artículo científico publicado en 2010

Development of a novel adjuvanted nasal vaccine: C48/80 associated with chitosan nanoparticles as a path to enhance mucosal immunity

artículo científico publicado en 2015

Effect of bismuth salts on systemic and mucosal immune responses to orally administered cholera toxin

artículo científico publicado en 1995

Effect of particulate adjuvant on the anthrax protective antigen dose required for effective nasal vaccination

artículo científico publicado en 2015

Effective induction of protective systemic immunity with nasally administered vaccines adjuvanted with IL-1.

artículo científico publicado en 2010

Generation of mucosal anti-human immunodeficiency virus type 1 T-cell responses by recombinant Mycobacterium smegmatis

artículo científico publicado en 2006

Genetic determinants of immune-response to a polysaccharide vaccine for typhoid.

artículo científico publicado en 2009

HIV vaccine development at Duke University Medical Center.

artículo científico publicado en 2000

Helper Th1 and Th2 cell responses following mucosal or systemic immunization with cholera toxin

artículo científico publicado en 1994

Identification of Novel Mast Cell Activators Using Cell-Based High-Throughput Screening

scientific article published on 27 March 2019

Identification of recombinant antibodies against multiple distinct toll-like receptors by homolog mining a single immune scFv phage library

artículo científico publicado en 2008

Immunization with the Haemophilus ducreyi hemoglobin receptor HgbA with adjuvant monophosphoryl lipid A protects swine from a homologous but not a heterologous challenge

artículo científico publicado en 2010

Increased immunogenicity of HIV envelope subunit complexed with alpha2-macroglobulin when combined with monophosphoryl lipid A and GM-CSF

scientific article published on 01 May 2002

Increased peanut-specific IgA levels in saliva correlate with food challenge outcomes after peanut sublingual immunotherapy.

scientific article published on 10 January 2012

Intranasal mRNA nanoparticle vaccination induces prophylactic and therapeutic anti-tumor immunity

artículo científico publicado en 2014

MRGPR-mediated activation of local mast cells clears cutaneous bacterial infection and protects against reinfection

artículo científico publicado en 2019

Mast cell activators: a new class of highly effective vaccine adjuvants

artículo científico publicado en 2008

Mast cell-derived particles deliver peripheral signals to remote lymph nodes

artículo científico publicado en 2009

Mast cell-derived tumor necrosis factor induces hypertrophy of draining lymph nodes during infection

artículo científico publicado en 2003

Mast cells augment adaptive immunity by orchestrating dendritic cell trafficking through infected tissues

artículo científico publicado en 2009

Mucosal and systemic adjuvant activity of alphavirus replicon particles.

artículo científico publicado en 2006

Mucosal immunity to infection with implications for vaccine development

artículo científico publicado en 1994

Mucosal immunization of lactating female rhesus monkeys with a transmitted/founder HIV-1 envelope induces strong Env-specific IgA antibody responses in breast milk

artículo científico publicado en 2013

Mucosal targeting of a BoNT/A subunit vaccine adjuvanted with a mast cell activator enhances induction of BoNT/A neutralizing antibodies in rabbits

artículo científico publicado en 2011

Non-replicating mucosal and systemic vaccines: quantitative and qualitative differences in the Ag-specific CD8(+) T cell population in different tissues

scientific article published on 01 March 2004

Novel mucosal adjuvant, mastoparan-7, improves cocaine vaccine efficacy

artículo científico publicado en 2020

Optimized Mucosal Modified Vaccinia Virus Ankara Prime/Soluble gp120 Boost HIV Vaccination Regimen Induces Antibody Responses Similar to Those of an Intramuscular Regimen

scientific article published on 28 June 2019

Oral immunogenicity of the plant proteinase bromelain

scientific article published on 05 September 2006

Perivascular dendritic cells elicit anaphylaxis by relaying allergens to mast cells via microvesicles

artículo científico publicado en 2018

Prolonged CD4+ cell/virus load discordance during treatment with protease inhibitor-based highly active antiretroviral therapy: immune response and viral control

artículo científico publicado en 2003

Salmonella typhimurium impedes innate immunity with a mast-cell-suppressing protein tyrosine phosphatase, SptP.

artículo científico publicado en 2013

Scale of health: indices of safety and efficacy in the evolving environment of large biological datasets

artículo científico publicado en 2014

Scarcity or absence of humoral immune responses in the plasma and cervicovaginal lavage fluids of heavily HIV-1-exposed but persistently seronegative women

artículo científico publicado en 2010

Stable dry powder formulation for nasal delivery of anthrax vaccine

artículo científico publicado en 2012

Synthetic mast-cell granules as adjuvants to promote and polarize immunity in lymph nodes

artículo científico publicado en 2012

The V3 domain of SIVmac251 gp120 contains a linear neutralizing epitope

artículo científico publicado en 1996

The contribution of type I interferon signaling to immunity induced by alphavirus replicon vaccines.

artículo científico publicado en 2008

The mast cell activator compound 48/80 is safe and effective when used as an adjuvant for intradermal immunization with Bacillus anthracis protective antigen

artículo científico publicado en 2009

Which comes first: the antigen or the adjuvant?

artículo científico publicado en 2014

Lista de obras de Herman Staats

A Mast Cell Degranulation Screening Assay for the Identification of Novel Mast Cell Activating Agents

A comparative evaluation of nasal and parenteral vaccine adjuvants to elicit systemic and mucosal HIV-1 peptide-specific humoral immune responses in cynomolgus macaques

A comparison of non-toxin vaccine adjuvants for their ability to enhance the immunogenicity of nasally-administered anthrax recombinant protective antigen.

A mastoparan-derived peptide has broad-spectrum antiviral activity against enveloped viruses

Alphavirus replicon particles acting as adjuvants promote CD8+ T cell responses to co-delivered antigen.

An entirely cell-based system to generate single-chain antibodies against cell surface receptors

Bridging Vaccine-Induced HIV-1 Neutralizing and Effector Antibody Responses in Rabbit and Rhesus Macaque Animal Models

Capric acid and hydroxypropylmethylcellulose increase the immunogenicity of nasally administered peptide vaccines

Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies.

Chaperoning vaccines

Cytokines as adjuvants for the induction of anti-human immunodeficiency virus peptide immunoglobulin G (IgG) and IgA antibodies in serum and mucosal secretions after nasal immunization

Cytokines: the future of intranasal vaccine adjuvants.

Detection of Mucosal Antibodies in HIV Type 1-Infected Individuals

Development of a bead immunoassay to measure Vi polysaccharide-specific serum IgG after vaccination with the Salmonella enterica serovar Typhi Vi polysaccharide

Development of a novel adjuvanted nasal vaccine: C48/80 associated with chitosan nanoparticles as a path to enhance mucosal immunity

Effect of bismuth salts on systemic and mucosal immune responses to orally administered cholera toxin

Effect of particulate adjuvant on the anthrax protective antigen dose required for effective nasal vaccination

Effective induction of protective systemic immunity with nasally administered vaccines adjuvanted with IL-1.

Generation of mucosal anti-human immunodeficiency virus type 1 T-cell responses by recombinant Mycobacterium smegmatis

Genetic determinants of immune-response to a polysaccharide vaccine for typhoid.

HIV vaccine development at Duke University Medical Center.

Helper Th1 and Th2 cell responses following mucosal or systemic immunization with cholera toxin

Identification of Novel Mast Cell Activators Using Cell-Based High-Throughput Screening

Identification of recombinant antibodies against multiple distinct toll-like receptors by homolog mining a single immune scFv phage library

Immunization with the Haemophilus ducreyi hemoglobin receptor HgbA with adjuvant monophosphoryl lipid A protects swine from a homologous but not a heterologous challenge

Increased immunogenicity of HIV envelope subunit complexed with alpha2-macroglobulin when combined with monophosphoryl lipid A and GM-CSF

Increased peanut-specific IgA levels in saliva correlate with food challenge outcomes after peanut sublingual immunotherapy.

Intranasal mRNA nanoparticle vaccination induces prophylactic and therapeutic anti-tumor immunity

MRGPR-mediated activation of local mast cells clears cutaneous bacterial infection and protects against reinfection

Mast cell activators: a new class of highly effective vaccine adjuvants

Mast cell-derived particles deliver peripheral signals to remote lymph nodes

Mast cell-derived tumor necrosis factor induces hypertrophy of draining lymph nodes during infection

Mast cells augment adaptive immunity by orchestrating dendritic cell trafficking through infected tissues

Mucosal and systemic adjuvant activity of alphavirus replicon particles.

Mucosal immunity to infection with implications for vaccine development

Mucosal immunization of lactating female rhesus monkeys with a transmitted/founder HIV-1 envelope induces strong Env-specific IgA antibody responses in breast milk

Mucosal targeting of a BoNT/A subunit vaccine adjuvanted with a mast cell activator enhances induction of BoNT/A neutralizing antibodies in rabbits

Non-replicating mucosal and systemic vaccines: quantitative and qualitative differences in the Ag-specific CD8(+) T cell population in different tissues

Novel mucosal adjuvant, mastoparan-7, improves cocaine vaccine efficacy

Optimized Mucosal Modified Vaccinia Virus Ankara Prime/Soluble gp120 Boost HIV Vaccination Regimen Induces Antibody Responses Similar to Those of an Intramuscular Regimen

Oral immunogenicity of the plant proteinase bromelain

Perivascular dendritic cells elicit anaphylaxis by relaying allergens to mast cells via microvesicles

Prolonged CD4+ cell/virus load discordance during treatment with protease inhibitor-based highly active antiretroviral therapy: immune response and viral control

Salmonella typhimurium impedes innate immunity with a mast-cell-suppressing protein tyrosine phosphatase, SptP.

Scale of health: indices of safety and efficacy in the evolving environment of large biological datasets

Scarcity or absence of humoral immune responses in the plasma and cervicovaginal lavage fluids of heavily HIV-1-exposed but persistently seronegative women

Stable dry powder formulation for nasal delivery of anthrax vaccine

Synthetic mast-cell granules as adjuvants to promote and polarize immunity in lymph nodes

The V3 domain of SIVmac251 gp120 contains a linear neutralizing epitope

The contribution of type I interferon signaling to immunity induced by alphavirus replicon vaccines.

The mast cell activator compound 48/80 is safe and effective when used as an adjuvant for intradermal immunization with Bacillus anthracis protective antigen

Which comes first: the antigen or the adjuvant?